Author

S. Kalachikov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. Tao· 1 shared I. Morozova· 1 shared J. J. Russo· 1 shared J. Ju· 1 shared M. Chien· 1 shared S. Jockusch· 1 shared S. Kumar· 1 shared X. Li· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. Tao

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sofosbuvir Terminated RNA is More Resistant to SARS-CoV-2 Proofreader than RNA Terminated by Remdesivir

S. Jockusch, C. Tao, X. Li, M. Chien, S. Kumar, I. Morozova, S. Kalachikov, J. J. Russo, J. Ju

This study compares the resistance of SARS-CoV-2 RNA terminated by Sofosbuvir and Remdesivir to exonuclease proofreading, finding Sofosbuvir-terminated RNA more resistant.

bioRxiv · Aug 7, 2020Pharmacology & Toxicology